Wegovy, its impact during pregnancy, breastfeeding, and contraception use
Wegovy, a subcutaneous injection used for weight management and lowering cardiovascular risks, is not considered safe to use during pregnancy or breastfeeding due to a lack of sufficient safety data and potential risks.
Pregnant women are advised to stop Wegovy at least two months before attempting to conceive, as animal studies have shown risks including birth defects and pregnancy loss. The FDA and the manufacturer recommend discontinuing Wegovy if pregnancy occurs, and emphasize the use of effective contraception while on the medication.
Regarding breastfeeding, there is no conclusive safety data on semaglutide (Wegovy's active ingredient) passage into breast milk or its effects on infants. Therefore, most healthcare providers recommend avoiding Wegovy during lactation and waiting until after weaning to resume treatment.
A pregnancy exposure registry has been established to collect data on outcomes when Wegovy is used during pregnancy, underscoring the need for careful monitoring. If you become pregnant while taking Wegovy, immediately contact your doctor.
Your doctor will likely recommend using birth control to prevent pregnancy while you take Wegovy and for two months after you stop taking Wegovy. They will also recommend waiting at least two months after your last dose of Wegovy before trying to conceive.
To learn more about the pregnancy registry for Wegovy, call 877-390-2760, visit the provided site, or talk with your doctor. It is crucial to discuss your concerns and options with your healthcare provider before making any decisions.
Remember, Wegovy contains the active drug semaglutide. Animal studies have shown fetal harm in offspring born to pregnant animals that were given Wegovy. The risks and benefits of Wegovy should be discussed with a doctor before taking the drug while breastfeeding.
If you're breastfeeding or planning to breastfeed, consider the potential effects of Wegovy on you and your child. It is essential to prioritise the health and safety of both you and your child when making decisions about medication use.
In summary, Wegovy should be avoided during pregnancy and breastfeeding due to potential fetal risks and an unknown safety profile. Women planning pregnancy should discontinue use well in advance and consult their healthcare providers for safer alternatives and guidance on family planning.
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- TMJ Osteoarthritis: A Comprehensive Look at Its Nature
- Symptoms, Diagnosis, and Management Strategies for High-functioning ADHD
- Struggles of Advanced Breast Cancer Patients in Receiving Necessary Treatments Due to Conflicts and Bias
